Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease
M Faria, MN de Pinho - Translational Research, 2021 - Elsevier
The prevalence of chronic kidney disease (CKD) in the worldwide population is currently
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease
M Faria, MN de Pinho - Translational research: the …, 2021 - pubmed.ncbi.nlm.nih.gov
The prevalence of chronic kidney disease (CKD) in the worldwide population is currently
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
M Faria, MN de Pinho - … Research: the Journal of Laboratory and …, 2020 - europepmc.org
The prevalence of chronic kidney disease (CKD) in the worldwide population is currently
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease
M Faria, MN de Pinho - Translational Research, 2021 - translationalres.com
The prevalence of chronic kidney disease (CKD) in the worldwide population is currently
estimated between 11% and 13%. Adequate renal clearance is compromised in these …
estimated between 11% and 13%. Adequate renal clearance is compromised in these …